Atlantic International Corp. (NASDAQ: ATLN) Stock Competitors & Peer Comparison
See ATLN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ATLN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ATLN | $0.90 | +0.00% | 68.6M | -0.68 | -$1.33 | N/A |
| RPRX | $56.57 | -2.09% | 25.1B | 10.78 | $5.25 | +1.60% |
| CORT | $117.80 | -2.80% | 12.7B | 336.57 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| KNSA | $78.53 | -0.90% | 6B | 80.96 | $0.97 | N/A |
| LQDA | $26.81 | -3.11% | 2.4B | 19.57 | $1.37 | N/A |
| PBH | $48.50 | -1.02% | 2.3B | 10.98 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $15.71 | -1.94% | 945M | -6.23 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
ATLN vs RPRX Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, RPRX has a market cap of 25.1B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while RPRX trades at $56.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas RPRX's P/E ratio is 10.78. In terms of profitability, ATLN's ROE is -83.20%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, ATLN is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
ATLN vs CORT Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, CORT has a market cap of 12.7B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while CORT trades at $117.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas CORT's P/E ratio is 336.57. In terms of profitability, ATLN's ROE is -83.20%, compared to CORT's ROE of +0.08%. Regarding short-term risk, ATLN is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
ATLN vs WBA Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas WBA's P/E ratio is -1.64. In terms of profitability, ATLN's ROE is -83.20%, compared to WBA's ROE of -0.57%. Regarding short-term risk, ATLN is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check WBA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
ATLN vs KNSA Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while KNSA trades at $78.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas KNSA's P/E ratio is 80.96. In terms of profitability, ATLN's ROE is -83.20%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, ATLN is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
ATLN vs LQDA Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, LQDA has a market cap of 2.4B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while LQDA trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas LQDA's P/E ratio is 19.57. In terms of profitability, ATLN's ROE is -83.20%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, ATLN is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
ATLN vs PBH Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, PBH has a market cap of 2.3B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while PBH trades at $48.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas PBH's P/E ratio is 10.98. In terms of profitability, ATLN's ROE is -83.20%, compared to PBH's ROE of +0.09%. Regarding short-term risk, ATLN is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
ATLN vs HROWL Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas HROWL's P/E ratio is N/A. In terms of profitability, ATLN's ROE is -83.20%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, ATLN is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
ATLN vs HROWM Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas HROWM's P/E ratio is N/A. In terms of profitability, ATLN's ROE is -83.20%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, ATLN is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
ATLN vs LTGO Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, LTGO has a market cap of 945M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while LTGO trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas LTGO's P/E ratio is -6.23. In terms of profitability, ATLN's ROE is -83.20%, compared to LTGO's ROE of N/A. Regarding short-term risk, ATLN is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
ATLN vs HELP Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, HELP has a market cap of 650.8M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while HELP trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas HELP's P/E ratio is -2.52. In terms of profitability, ATLN's ROE is -83.20%, compared to HELP's ROE of -0.71%. Regarding short-term risk, ATLN is more volatile compared to HELP. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
ATLN vs SVA Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas SVA's P/E ratio is -5.68. In terms of profitability, ATLN's ROE is -83.20%, compared to SVA's ROE of -0.01%. Regarding short-term risk, ATLN is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
ATLN vs CUVL Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, CUVL has a market cap of 275.6M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while CUVL trades at $5.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas CUVL's P/E ratio is 11.79. In terms of profitability, ATLN's ROE is -83.20%, compared to CUVL's ROE of N/A. Regarding short-term risk, ATLN is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check CUVL's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
ATLN vs CELG-RI Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, CELG-RI has a market cap of 241M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while CELG-RI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, ATLN's ROE is -83.20%, compared to CELG-RI's ROE of +0.47%. Regarding short-term risk, ATLN is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check CELG-RI's competition here
High Tide Inc. (NASDAQ: HITI)
ATLN vs HITI Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, HITI has a market cap of 226.7M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while HITI trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas HITI's P/E ratio is -9.53. In terms of profitability, ATLN's ROE is -83.20%, compared to HITI's ROE of -0.36%. Regarding short-term risk, ATLN is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check HITI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
ATLN vs ETRA Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, ETRA has a market cap of 182.6M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while ETRA trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas ETRA's P/E ratio is -3.25. In terms of profitability, ATLN's ROE is -83.20%, compared to ETRA's ROE of N/A. Regarding short-term risk, ATLN is more volatile compared to ETRA. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
ATLN vs TRXB Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, TRXB has a market cap of 113.3M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while TRXB trades at $13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas TRXB's P/E ratio is -5.51. In terms of profitability, ATLN's ROE is -83.20%, compared to TRXB's ROE of N/A. Regarding short-term risk, ATLN is more volatile compared to TRXB. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check TRXB's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
ATLN vs CTOR Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, CTOR has a market cap of 71.6M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while CTOR trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas CTOR's P/E ratio is -1.64. In terms of profitability, ATLN's ROE is -83.20%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, ATLN is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check CTOR's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
ATLN vs RTSN Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, RTSN has a market cap of 44.7M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while RTSN trades at $11.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas RTSN's P/E ratio is -4.57. In terms of profitability, ATLN's ROE is -83.20%, compared to RTSN's ROE of N/A. Regarding short-term risk, ATLN is more volatile compared to RTSN. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
ATLN vs RAD Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas RAD's P/E ratio is -0.05. In terms of profitability, ATLN's ROE is -83.20%, compared to RAD's ROE of +2.76%. Regarding short-term risk, ATLN is more volatile compared to RAD. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
ATLN vs GLTO Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas GLTO's P/E ratio is -1.78. In terms of profitability, ATLN's ROE is -83.20%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, ATLN is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
ATLN vs NSRX Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, NSRX has a market cap of 27.8M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while NSRX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas NSRX's P/E ratio is -4.49. In terms of profitability, ATLN's ROE is -83.20%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, ATLN is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
ATLN vs SCYX Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, SCYX has a market cap of 25.1M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while SCYX trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas SCYX's P/E ratio is -1.17. In terms of profitability, ATLN's ROE is -83.20%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, ATLN is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check SCYX's competition here
Cosmos Health Inc. (NASDAQ: COSM)
ATLN vs COSM Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, COSM has a market cap of 20.8M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while COSM trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas COSM's P/E ratio is -0.52. In terms of profitability, ATLN's ROE is -83.20%, compared to COSM's ROE of -1.19%. Regarding short-term risk, ATLN is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check COSM's competition here
Cerenome, Inc. (NASDAQ: CNSY)
ATLN vs CNSY Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, CNSY has a market cap of 12M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while CNSY trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas CNSY's P/E ratio is -0.41. In terms of profitability, ATLN's ROE is -83.20%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, ATLN is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
ATLN vs BFRI Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, BFRI has a market cap of 11.4M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while BFRI trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas BFRI's P/E ratio is -1.62. In terms of profitability, ATLN's ROE is -83.20%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, ATLN is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
ATLN vs CJJD Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas CJJD's P/E ratio is -0.46. In terms of profitability, ATLN's ROE is -83.20%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, ATLN is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
ATLN vs SSY Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas SSY's P/E ratio is -2.86. In terms of profitability, ATLN's ROE is -83.20%, compared to SSY's ROE of -0.09%. Regarding short-term risk, ATLN is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for ATLN.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
ATLN vs SCNX Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while SCNX trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas SCNX's P/E ratio is -1.54. In terms of profitability, ATLN's ROE is -83.20%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, ATLN is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
ATLN vs BGMS Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, BGMS has a market cap of 5.1M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while BGMS trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas BGMS's P/E ratio is -0.26. In terms of profitability, ATLN's ROE is -83.20%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, ATLN is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check BGMS's competition here
POMDOCTOR Ltd (NASDAQ: POM)
ATLN vs POM Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, POM has a market cap of 4.7M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while POM trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas POM's P/E ratio is -0.12. In terms of profitability, ATLN's ROE is -83.20%, compared to POM's ROE of +0.16%. Regarding short-term risk, ATLN is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check POM's competition here
Eocene Ltd. (NASDAQ: EOCN)
ATLN vs EOCN Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, EOCN has a market cap of 3.3M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while EOCN trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas EOCN's P/E ratio is -0.23. In terms of profitability, ATLN's ROE is -83.20%, compared to EOCN's ROE of N/A. Regarding short-term risk, ATLN is more volatile compared to EOCN. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check EOCN's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
ATLN vs BFRIW Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, BFRIW has a market cap of 3.2M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while BFRIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas BFRIW's P/E ratio is -0.01. In terms of profitability, ATLN's ROE is -83.20%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, ATLN is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check BFRIW's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
ATLN vs MDVL Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas MDVL's P/E ratio is -0.05. In terms of profitability, ATLN's ROE is -83.20%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, ATLN is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for ATLN.Check MDVL's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
ATLN vs PAVS Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, PAVS has a market cap of 2.9M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while PAVS trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas PAVS's P/E ratio is -0.04. In terms of profitability, ATLN's ROE is -83.20%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, ATLN is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
ATLN vs ATNFW Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas ATNFW's P/E ratio is N/A. In terms of profitability, ATLN's ROE is -83.20%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, ATLN is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
ATLN vs BGMSP Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, ATLN's ROE is -83.20%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, ATLN is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
ATLN vs AZNH Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas AZNH's P/E ratio is 38.35. In terms of profitability, ATLN's ROE is -83.20%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, ATLN is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
ATLN vs LFLYW Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, ATLN's ROE is -83.20%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, ATLN is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check LFLYW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
ATLN vs PRPH Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, PRPH has a market cap of 119.1K. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas PRPH's P/E ratio is N/A. In terms of profitability, ATLN's ROE is -83.20%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, ATLN is more volatile compared to PRPH. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check PRPH's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
ATLN vs CPD Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, CPD has a market cap of 0. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas CPD's P/E ratio is N/A. In terms of profitability, ATLN's ROE is -83.20%, compared to CPD's ROE of N/A. Regarding short-term risk, ATLN is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check CPD's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
ATLN vs OREX Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, OREX has a market cap of 0. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas OREX's P/E ratio is -0.14. In terms of profitability, ATLN's ROE is -83.20%, compared to OREX's ROE of -0.54%. Regarding short-term risk, ATLN is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for ATLN.Check OREX's competition here
POZEN Inc. (NASDAQ: POZN)
ATLN vs POZN Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, POZN has a market cap of 0. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas POZN's P/E ratio is N/A. In terms of profitability, ATLN's ROE is -83.20%, compared to POZN's ROE of +0.61%. Regarding short-term risk, ATLN is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check POZN's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
ATLN vs IPXL Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas IPXL's P/E ratio is -10.11. In terms of profitability, ATLN's ROE is -83.20%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, ATLN is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check IPXL's competition here
Shire plc (NASDAQ: SHPG)
ATLN vs SHPG Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas SHPG's P/E ratio is 11.35. In terms of profitability, ATLN's ROE is -83.20%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, ATLN is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check SHPG's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
ATLN vs ESRX Comparison October 2026
Atlantic International Corp. (NASDAQ: ATLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ATLN stands at 68.6M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, ATLN is priced at $0.90 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ATLN currently has a P/E ratio of -0.68, whereas ESRX's P/E ratio is 10.69. In terms of profitability, ATLN's ROE is -83.20%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, ATLN is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for ATLN.Check ESRX's competition here